Postoperative Nausea and Vomiting Clinical Trial
Official title:
ST36 Acupoint Injection With Anisodamine for Postoperative Nausea and Vomiting in Women Following Bariatric Surgery: A Multicentre, Randomised, Double-Blind Controlled Trial.
Postoperative nausea and vomiting (PONV) is particularly one of the most common complications after laparoscopic sleeve gastrectomy (LSG). It can lead to serious adverse events and delayed activity, and prolong the time of rehabilitation and discharge. Numbers of studies have been focused on identifying risk factors and therapies of PONV. Unfortunately, there' no consistent comments for PONV prevention in women after LSG. Notably, Zusanli (ST36) acupoint and anisodamine have been evidenced to treat various gastrointestinal conditions. The primary outcome of this study was to evaluate the impact of anisodamine injection in ST36 on PONV in women following bariatric surgery.
Status | Recruiting |
Enrollment | 300 |
Est. completion date | May 1, 2024 |
Est. primary completion date | February 1, 2024 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: 1. Female patients with an American Society of Anesthesia (ASA) physical status I-IV 2. Scheduled for elective bariatric surgery 3. Written informed consent was obtained Exclusion Criteria: 1. Patients with contraindications for acupoint injection 2. Difficulty in communicating with patients 3. Allergic diathesis for drugs used in the study or serious illness (heart, lung, kidney, or liver, et. al) 4. Coagulation dysfunction 5. Pre-existing psychological or neurological disorder 6. Pre-use medicine before surgery that would interferenced objective assessment (including the use of opioids, antiemetics or glucocorticoids) 7. Gastroesophageal reflux disease |
Country | Name | City | State |
---|---|---|---|
China | Beijing Chao-Yang Hospital, Capital Medical University | Beijing | |
China | The First Affiliated Hospital of Jinan University | Guangzhou | Guangdong |
China | The Second Hospital of Anhui Medical University | Hefei | Anhui |
China | Jiangsu Province Hospital | Nanjing | Jiangsu |
China | Huashan Hospital Affiliated to Fudan University | Shanghai | |
China | The Affiliated Hospital of Xuzhou Medical University | Xuzhou | Jiangsu |
China | Henan Provincial People's Hospital | Zhengzhou | Henan |
Lead Sponsor | Collaborator |
---|---|
The Second Hospital of Anhui Medical University | Beijing Chao Yang Hospital, First Affiliated Hospital of Jinan University, Henan Provincial People's Hospital, Huashan Hospital, The Affiliated Hospital of Xuzhou Medical University, The First Affiliated Hospital with Nanjing Medical University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Consumption of propofol | The total consumption of propofol during the surgery | During the bariatric surgery | |
Other | Consumption of remifentanil | The total consumption of remifentanil during the surgery | During the surgery | |
Other | Consumption of sufentanil | The total consumption of sufentanil during the surgery | During the surgery and postoperative 1-3 days | |
Other | Duration of anesthesia | From beginning to the end of anesthesia | At the end of anesthesia | |
Other | Duration of surgery | From beginning to the end of surgery | At the end of surgery | |
Primary | The incidence and severity of PONV | The incidence and severity of PONV after bariatric surgery | At 0-2 hours after surgery | |
Primary | The incidence and severity of PONV | Total usage of rescue antiemetic drugs after bariatric surgery | At 2-6 hours after surgery | |
Primary | The incidence and severity of PONV | The incidence and severity of PONV after bariatric surgery | At 6-12 hours after surgery | |
Primary | The incidence and severity of PONV | The incidence and severity of PONV after bariatric surgery | At 12-24 hours after surgery | |
Primary | The usage of rescue antiemetic drugs | Total usage of rescue antiemetic drugs after bariatric surgery | During 3 months after bariatric surgery | |
Secondary | 15-item Quality of Recovery(QoR-15) | QoR-15 will be used to evaluate recovery quality after anesthesia, including 15 items covering sleep, satisfaction, emotion and pain et. al,total score ranges from 0 to 150,the higher score means the higher quality of recovery. | Postoperative 24 hours | |
Secondary | Postoperative pain | Patients will be asked about their pain level at rest and moving on a numeric rating scale (0=no pain,10=worst pain imaginable) . | At 0-24 and 24-72 hours after surgery | |
Secondary | Consumption of analgesics | Cumulative analgesic consumption after surgery | During 3 months after bariatric surgery | |
Secondary | Ambulation time | Interval time of patients' transit from bed rest to ambulation after surgery | Postoperative 1-3 days | |
Secondary | Postoperative food and water intake time | Duration of eating and drinking after surgery | Postoperative 1-3 days | |
Secondary | Postoperative hospitalization duration | Days of hospital staying after surgery | 2 weeks after surgery | |
Secondary | Pittsburgh sleep quality index | Pittsburgh sleep quality index will be used to evaluate quality of sleep. The higher score means the lower quality of sleep. | Before surgery and at postoperative 3 months | |
Secondary | Gastrointestinal Symptom Rating Scale | Gastrointestinal symptom rating scale (GSRS) will be used to assess gastrointestinal function. The score ranges from 0 to 45. The higher score means poorer gastrointestinal function . | Before surgery and at postoperative 3 months | |
Secondary | Hamilton depression rating scale | Hamilton depression scale (HAMD) will be used to assess depression. HAMD 24 item version score range 0-96. The higher score means the higher possibility of depression. | Before surgery and at postoperative 3 months | |
Secondary | Hamilton anxiety rating scale | Hamilton anxiety scale (HAM-A) will be used to assess anxiety. Total score ranges from 0 to 56, the higher the score is, the more serious the anxiety is. | Before surgery and at postoperative 3 months | |
Secondary | The MOS item short from health survey ,SF-36 | Concise health status scale | Before surgery and at the postoperative 3 months.The scale consists of 36 items,divided into 8 sections,score of each section ranges from 0 to 100, the higher the score is, the healthier is. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04466046 -
The Effect on Anxiolytics With Type of Antiemetic Agents on Postoperative Nausea and Vomiting in High Risk Patients
|
||
Completed |
NCT03139383 -
Dextrose Containing Fluid and the Postoperative Nausea and Vomiting in the Gynecologic Laparoscopic Surgery
|
N/A | |
Recruiting |
NCT04069806 -
Preoperative Oral Carbohydrate for Nausea and Vomiting Prevention During Cesarian Section
|
N/A | |
Completed |
NCT04043247 -
Transcutaneous Electrical Acupoint Stimulation for Prevention of Postoperative Nausea and Vomiting
|
N/A | |
Terminated |
NCT01975727 -
Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting
|
Phase 2 | |
Completed |
NCT03662672 -
Rib Raising for Post-operative Ileus
|
N/A | |
Completed |
NCT00090155 -
2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)
|
Phase 3 | |
Completed |
NCT02480088 -
Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 Polymorphism
|
Phase 4 | |
Recruiting |
NCT06137027 -
Cannabidiol Oil Extract for Prevention of Postoperative Nausea and Vomiting
|
Early Phase 1 | |
Not yet recruiting |
NCT05529004 -
A 6 Months Double Blind Trial to Prevent PONV in Laparoscopic Cholecystectomy
|
Phase 2 | |
Completed |
NCT02944942 -
Risk Factors for Postoperative Nausea/Vomiting
|
N/A | |
Recruiting |
NCT02571153 -
Low Doses of Ketamine and Postoperative Quality of Recovery
|
Phase 4 | |
Completed |
NCT02550795 -
Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer
|
N/A | |
Completed |
NCT02449291 -
Study of APD421 as PONV Treatment (no Prior Prophylaxis)
|
Phase 3 | |
Recruiting |
NCT01442012 -
Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting in Ambulatory Surgery
|
N/A | |
Completed |
NCT01478165 -
Comparison of TIVA (Total Intravenous Anesthesia) and TIVA Plus Palonosetron in Preventing Postoperative Nausea and Vomiting
|
N/A | |
Unknown status |
NCT01268748 -
Single Port Versus Four Ports Laparoscopic Cholecystectomy and Early Postoperative Pain
|
N/A | |
Completed |
NCT02143531 -
Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting
|
Phase 4 | |
Completed |
NCT00734929 -
Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy
|
Phase 4 | |
Withdrawn |
NCT00151099 -
Safety of Preoperative Oral Administration of a High Caloric Drink With Protein
|
Phase 4 |